JPH0543697B2 - - Google Patents
Info
- Publication number
- JPH0543697B2 JPH0543697B2 JP86187653A JP18765386A JPH0543697B2 JP H0543697 B2 JPH0543697 B2 JP H0543697B2 JP 86187653 A JP86187653 A JP 86187653A JP 18765386 A JP18765386 A JP 18765386A JP H0543697 B2 JPH0543697 B2 JP H0543697B2
- Authority
- JP
- Japan
- Prior art keywords
- reference example
- product
- title product
- cyclohexyl
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/14—Angiotensins: Related peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0227—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/86—Renin inhibitors
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Polyamides (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76416885A | 1985-08-09 | 1985-08-09 | |
| US764168 | 1985-08-09 | ||
| US06/858,324 US4729985A (en) | 1985-08-09 | 1986-04-30 | Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues |
| US858324 | 1986-04-30 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6253952A JPS6253952A (ja) | 1987-03-09 |
| JPH0543697B2 true JPH0543697B2 (https=) | 1993-07-02 |
Family
ID=27117410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP61187653A Granted JPS6253952A (ja) | 1985-08-09 | 1986-08-09 | レニン阻害剤製造用中間体の立体選択的製法 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4729985A (https=) |
| EP (1) | EP0212903B1 (https=) |
| JP (1) | JPS6253952A (https=) |
| KR (1) | KR890003603B1 (https=) |
| CN (1) | CN86105870A (https=) |
| AT (1) | ATE84046T1 (https=) |
| AU (1) | AU576970B2 (https=) |
| CA (1) | CA1294736C (https=) |
| DE (1) | DE3687380T2 (https=) |
| DK (1) | DK379186A (https=) |
| EG (1) | EG17971A (https=) |
| ES (1) | ES2000852A6 (https=) |
| FI (1) | FI86192C (https=) |
| GR (1) | GR862078B (https=) |
| HU (1) | HU207101B (https=) |
| IE (1) | IE58524B1 (https=) |
| IL (1) | IL79626A0 (https=) |
| NO (1) | NO170725C (https=) |
| NZ (1) | NZ217127A (https=) |
| PH (1) | PH24494A (https=) |
| PT (1) | PT83172B (https=) |
| YU (1) | YU45355B (https=) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4727060A (en) * | 1984-11-13 | 1988-02-23 | Ciba-Geigy Corporation | Novel 5-amino-4-hydroxyvaleryl derivatives |
| DE3538749A1 (de) * | 1985-10-31 | 1987-05-07 | Merck Patent Gmbh | Peptide |
| FI870474A7 (fi) * | 1986-02-07 | 1987-08-08 | Ciba Geigy Ag | Med svavelhaltiga grupper substituerade 5-amino-4-hydroxivalerylderivat. |
| DE3626130A1 (de) * | 1986-08-01 | 1988-02-11 | Merck Patent Gmbh | Aminosaeurederivate |
| US4681972A (en) * | 1986-09-16 | 1987-07-21 | Warner-Lambert Company | Separation of diastereomers |
| US4851387A (en) * | 1986-10-14 | 1989-07-25 | Banyu Pharmaceutical Co., Ltd. | 5-substituted amino-4-hydroxy-pentanoic acid derivatives and their use |
| US4927565A (en) * | 1986-12-19 | 1990-05-22 | Banyu Pharmaceutical Co., Ltd. | 5-substituted amino-4-hydroxy-pentenoic acid derivatives and their use |
| US4758584A (en) * | 1987-02-05 | 1988-07-19 | Ciba-Geigy Corporation | Antihypertensive 5-amino-4-hydroxyvaleryl derivatives substituted by sulphur-containing groups |
| EP0297816B1 (en) * | 1987-07-01 | 1994-03-02 | Pfizer Inc. | Homocyclostatine and cyclostatine containing polypeptides as antihypertensive agents |
| US4859654A (en) * | 1987-07-01 | 1989-08-22 | Pfizer Inc. | Homocyclostatine and cyclostatine containing polypeptides as antihypertensive agents |
| EP0312158A3 (en) * | 1987-10-13 | 1990-07-25 | Merck & Co. Inc. | Tetrapeptide renin inhibitors having novel c-terminal amino acid amide |
| GB8728560D0 (en) * | 1987-12-07 | 1988-01-13 | Glaxo Group Ltd | Chemical compounds |
| GB8728561D0 (en) * | 1987-12-07 | 1988-01-13 | Glaxo Group Ltd | Chemical compounds |
| EP0326364B1 (en) * | 1988-01-26 | 1994-06-22 | Sankyo Company Limited | Renin inhibitory oligopeptides, their preparation and use |
| JPH03502328A (ja) * | 1988-02-01 | 1991-05-30 | ジ・アップジョン・カンパニー | 極性末端基類を有するレニン抑制ペプチド類 |
| JPS6486550A (en) * | 1988-08-19 | 1989-03-31 | Seiko Epson Corp | Complementary mos integrated circuit |
| US5436339A (en) * | 1991-03-06 | 1995-07-25 | Abbott Laboratories | Process for the preparation of a substituted diaminoalcohol |
| US5238935A (en) * | 1991-05-20 | 1993-08-24 | Schering Corporation | N-acyl-tetrahydroisoquinolines as inhibitors of acyl-coenzyme A: cholesterol acyl transferase |
| US5124337A (en) * | 1991-05-20 | 1992-06-23 | Schering Corporation | N-acyl-tetrahydroisoquinolines as inhibitors of acyl-coenzyme a:cholesterol acyl transferase |
| TW217410B (https=) * | 1992-04-01 | 1993-12-11 | Ciba Geigy | |
| MY119161A (en) * | 1994-04-18 | 2005-04-30 | Novartis Ag | Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities |
| EP0702004A2 (de) * | 1994-09-15 | 1996-03-20 | Ciba-Geigy Ag | 2,9-Diamino- und 2-amino-8-carbamoyl-4-hydroxy-alkansäureamid-derivative |
| EP0716077A1 (de) * | 1994-12-08 | 1996-06-12 | Ciba-Geigy Ag | Aromatisch substituierte Omega-Aminoalkansäureamide und Alkansäurediamide und ihre Verwendung als Renininhibitoren |
| CA2191924A1 (en) * | 1995-12-05 | 1997-06-06 | Kevin Felsenstein | 5-amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of .beta.-amyloid protein production |
| US5703129A (en) * | 1996-09-30 | 1997-12-30 | Bristol-Myers Squibb Company | 5-amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of β-amyloid protein production |
| DE60124080T2 (de) | 2000-03-23 | 2007-03-01 | Elan Pharmaceuticals, Inc., San Francisco | Verbindungen und verfahren zur behandlung der alzheimerschen krankheit |
| EP1299352B1 (en) | 2000-06-30 | 2005-12-28 | Elan Pharmaceuticals, Inc. | Compounds to treat alzheimer's disease |
| PE20020276A1 (es) | 2000-06-30 | 2002-04-06 | Elan Pharm Inc | COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER |
| US6846813B2 (en) | 2000-06-30 | 2005-01-25 | Pharmacia & Upjohn Company | Compounds to treat alzheimer's disease |
| EP1401452A1 (en) | 2001-06-27 | 2004-03-31 | Elan Pharmaceuticals, Inc. | Beta-hydroxyamine derivatives useful in the treatment of alzheimer's disease |
| BR112012003255B1 (pt) * | 2009-08-11 | 2018-10-23 | Novartis Ag | processo de abertura de anel de lactonas e lactamas |
| CN105195868B (zh) * | 2015-11-12 | 2018-05-15 | 上海电气核电设备有限公司 | 一种机器人焊接系统及其焊接方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4163676A (en) * | 1978-04-03 | 1979-08-07 | Blue Cross Laboratories | Ethanol-modified lecithin cookware spray composition |
| NO812612L (no) * | 1980-08-06 | 1982-02-08 | Ferring Pharma Ltd | Enzym-inhibitorer. |
| US4478826A (en) * | 1981-10-08 | 1984-10-23 | Merck & Co., Inc. | Renin inhibitory peptides |
| CA1258748A (en) * | 1981-10-08 | 1989-08-22 | Daniel F. Veber | Renin inhibitory peptides |
| US4470971A (en) | 1981-10-19 | 1984-09-11 | Merck & Co., Inc. | Renin inhibitory peptides having His13 |
| US4397786A (en) | 1981-11-23 | 1983-08-09 | Merck & Co., Inc. | Method of preparing statine and derivatives |
| CA1245217A (en) * | 1981-12-10 | 1988-11-22 | Joshua S. Boger | Renin inhibitory peptides having phe su13 xx deletion |
| EP0316965A3 (en) * | 1983-02-07 | 1989-08-09 | Aktiebolaget Hässle | Enzyme inhibitors |
| US4613676A (en) * | 1983-11-23 | 1986-09-23 | Ciba-Geigy Corporation | Substituted 5-amino-4-hydroxyvaleryl derivatives |
| CA1254699A (en) * | 1984-03-12 | 1989-05-23 | Jasjit S. Bindra | Renin inhibitors containing statine or derivatives thereof |
| US4661473A (en) * | 1984-03-27 | 1987-04-28 | Merck & Co., Inc. | Renin inhibitors containing peptide isosteres |
| DK356085A (da) * | 1984-08-06 | 1986-02-07 | Upjohn Co | Reninhaemmende peptid eller et farmaceutisk acceptabelt syreadditionssalt deraf |
| DE3512128A1 (de) * | 1985-04-03 | 1986-10-09 | Merck Patent Gmbh, 6100 Darmstadt | Peptide |
-
1986
- 1986-04-30 US US06/858,324 patent/US4729985A/en not_active Expired - Fee Related
- 1986-08-04 AT AT86305995T patent/ATE84046T1/de not_active IP Right Cessation
- 1986-08-04 DE DE8686305995T patent/DE3687380T2/de not_active Expired - Fee Related
- 1986-08-04 EP EP86305995A patent/EP0212903B1/en not_active Expired - Lifetime
- 1986-08-05 IL IL79626A patent/IL79626A0/xx not_active IP Right Cessation
- 1986-08-06 GR GR862078A patent/GR862078B/el unknown
- 1986-08-07 CA CA000515464A patent/CA1294736C/en not_active Expired - Lifetime
- 1986-08-07 PH PH34110A patent/PH24494A/en unknown
- 1986-08-07 NZ NZ217127A patent/NZ217127A/xx unknown
- 1986-08-08 ES ES8600952A patent/ES2000852A6/es not_active Expired
- 1986-08-08 FI FI863250A patent/FI86192C/fi not_active IP Right Cessation
- 1986-08-08 DK DK379186A patent/DK379186A/da not_active Application Discontinuation
- 1986-08-08 IE IE214386A patent/IE58524B1/en not_active IP Right Cessation
- 1986-08-08 PT PT83172A patent/PT83172B/pt not_active IP Right Cessation
- 1986-08-08 YU YU1422/86A patent/YU45355B/xx unknown
- 1986-08-08 KR KR1019860006535A patent/KR890003603B1/ko not_active Expired
- 1986-08-08 NO NO863202A patent/NO170725C/no unknown
- 1986-08-08 HU HU863517A patent/HU207101B/hu not_active IP Right Cessation
- 1986-08-08 AU AU61021/86A patent/AU576970B2/en not_active Ceased
- 1986-08-09 CN CN198686105870A patent/CN86105870A/zh active Pending
- 1986-08-09 JP JP61187653A patent/JPS6253952A/ja active Granted
- 1986-08-10 EG EG503/86A patent/EG17971A/xx active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0543697B2 (https=) | ||
| JP2525732B2 (ja) | ペプチジルアミノジオ−ル | |
| AU599581B2 (en) | Peptidylaminodiols | |
| US5338726A (en) | Endothelin converting enzyme inhibitors | |
| US6235717B1 (en) | Pharmaceutical compounds | |
| JPH04352757A (ja) | アミノ酸誘導体 | |
| US4629784A (en) | Synthesis of cyclopropane amino acids | |
| KR900008006B1 (ko) | 비교적 저분자량의 폴리펩티드 레닌 억제제 | |
| WO1986000896A1 (en) | NOVEL PROCESS FOR THE PREPARATION OF CIS, ENDOOCTAHYDROCYCLOPENTA ADb BDPYRROLE-2-CARBOXYLATE | |
| US4665055A (en) | Peptide renin inhibitors | |
| JPH058191B2 (https=) | ||
| JPH01502021A (ja) | ラクタムプソイドジペプチドを有するレニン抑制物質 | |
| JPH0647599B2 (ja) | ヘプタノイル―Ｇｌｕ―Ａｓｐ―Ａｌａ―アミノ酸系免疫賦活薬 | |
| US4864017A (en) | Novel renin inhibiting peptides having a dihyroxyethylene isostere transition state insert | |
| DE60301774T2 (de) | Verfahren zur Synthese von (2S,3aS,7aS)-1-((S)-Alanyl)-octahydro-1H-indol-2-carbonsäurederivaten und Verwendung in der Synthese von Perindopril | |
| FR2487341A1 (fr) | Tripeptides inhibiteurs de l'enzyme de transformation de l'angiotensine | |
| US4948913A (en) | Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues | |
| US4992562A (en) | Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues | |
| Boden et al. | Rationally designed ‘dipeptoid’analogues of cholecystokinin (CCK): C-terminal structure-activity relationships of α-methyl tryptophan derivatives | |
| IL90031A (en) | Amino acid esters, a process for the preparation thereof, pharmaceuticals containing them, and the use thereof | |
| US4442030A (en) | Process for preparing carboxyalkyl dipeptides | |
| SK279617B6 (sk) | Trifluórmetylmerkaptánové a merkaptoacylové derivá | |
| KR870000371B1 (ko) | 폴리펩타이드 유도체의 제조방법 | |
| AU609774B2 (en) | Peptidylaminodiols | |
| JPS63270649A (ja) | ５−置換アミノ−４−ヒドロキシペンテン酸誘導体及びその用途 |